Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net Loss	$ (9,109,756)	$ (3,618,523)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock compensation	0	23,650
Depreciation and amortization	143,627	186,519
(Gain) loss on sale of assets	(1,442)	1,527
Gain on forgiveness of loan	0	(23,303)
Gain on extinguishment of debt	(119,264)	(136,666)
Financing expense	0	0
Amortization of debt discount	1,501,582	413,180
Initial derivative expense	379,213	(0)
Loss on fair value of compound embedded derivative	4,292,576	354,952
Right-of-use asset/liability	(53,817)	52,830
Changes in operating assets & liabilities
Prepaid expenses	46,612	(70,113)
Accounts payable and accrued liabilities	808,002	211,608
Related party advances	(2,800)	0
Deferred revenue	(71,305)	(30,624)
Net cash used in operating activities	(2,186,772)	(2,634,963)
Cash Flows from Investing Activities
Business acquisitions and dispositions	87,869	(165,000)
Capital expenditures	(24,456)	(256,156)
Net cash provided (used) in investing activities	63,413	(421,156)
Cash Flows from Financing Activities
Proceeds from notes payable	1,104,448	150,000
Proceeds from convertible notes payable	1,213,989	2,096,681
Repayments of convertible notes payable	(108,371)	(207,863)
Repayments of notes payable	0	(8,609)
Payment of note payable	0	(2,354)
Issuance of common stock	0	1,180,000
Net cash provided by financing activities	2,210,066	3,207,855
Increase in Cash	86,707	151,736
Cash at beginning of period	39,623	122,176
Cash (and equivalents) at end of period	126,330	273,912
Supplemental Cash Flow Information
Cash paid for interest	66,200	8,303
Cash paid for income taxes	0	0
Non-cash investing and financing activities:
Conversion of note payable and accrued interest to common stock	186,043	0
Initial recognition of derivative liability as debt discount	342,019	(0)
Net assets disposed of	$ 87,869	$ 0